➢
The updated 2017 International Myeloma Working Group guidelines consider
PET/CT as a valuable tool in many indications, including the work-up of patients
with MM, and in fact stated that PET/CT is mandatory to confirm a diagnosis of
solitary plasmacytoma
➢
ILROG recommends that PET/CT should be performed as standard work-up for
SP, particularly when whole body MRI is of limited availability